The association between cement type and the subsequent risk of revision surgery in primary total hip replacement.

Acta Orthopaedica
Lea Trela-LarsenMichael Richard Whitehouse

Abstract

Background and purpose - To further improve the success of joint replacement surgery, attention needs to be paid to variations associated with improved or worsened outcomes. We investigated the association between the type of bone cement used and the risk of revision surgery after primary total hip replacement. Methods - We conducted a prospective study of data from the National Joint Registry for England and Wales between April 1, 2003 and December 31, 2013. 199,205 primary total hip replacements performed for osteoarthritis where bone cement was used were included. A multilevel over-dispersed piecewise Poisson model was used to estimate differences in the rate of revision by bone cement type adjusted for implant type, head size, age, sex, ASA grade, and surgical approach. Results - The rate of revision was higher in DePuy CMW3 medium viscosity with gentamicin (IRR 2.0, 95% CI 1.5-2.7) and DePuy SmartSet high viscosity plain (IRR 2.7, 95% CI 1.1-5.5), and lower in DePuy CMW1 high viscosity plain (IRR 0.44, 95% CI 0.19-0.89) bone cements compared with Heraeus Palacos high viscosity with gentamicin. Revision rates were similar between plain and antibiotic-loaded bone cement. Interpretation - The majority of bone cements performe...Continue Reading

References

Jun 1, 1990·The Journal of Arthroplasty·M M McQueenL Verity
Nov 1, 1989·The Journal of Bone and Joint Surgery. British Volume·P G HopeR A Elson
Oct 12, 2000·Acta Orthopaedica Scandinavica·L I HavelinS E Vollset
Oct 1, 2003·The Journal of Bone and Joint Surgery. British Volume·A W BlomG C Bannister
Jul 5, 2006·The Journal of Bone and Joint Surgery. American Volume·Ian D Learmonth
Nov 11, 2006·Annual Review of Public Health·Elaine Larson
Aug 4, 2009·Journal of the Royal Statistical Society. Series A, (Statistics in Society)·William J BrowneMartin J Green
Jun 24, 2010·The Journal of Arthroplasty·Javad ParviziKevin J Bozic
Dec 13, 2012·Epidemiology·Sander Greenland, Charles Poole
Nov 21, 2014·BMC Musculoskeletal Disorders·J Viktor LindgrenGöran Garellick

❮ Previous
Next ❯

Software Mentioned

Stata
DePuy
MLwiN

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.